Skip to main content

Find Clinical Trials

Home
Conditions
Eczema

Clinical trial condition

Eczema

Explore clinical trials studying Eczema. Study availability and eligibility vary by location and protocol.

141 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Eczema trial results

Completed

Steroid-reducing Effects of Crisaborole

NCT03832010

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

View Trial Details

Completed

Acceptance and Commitment Therapy-based Eczema Management Programme

NCT04919330

Conditions: Dermatitis, Eczema, Skin Diseases, +2 more
Locations: Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital Tuenmen, New Territories, Hong Kong

View Trial Details

Completed

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

NCT01916980

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermal Pruritus, Dermatitis, +10 more
Locations: Not specified

View Trial Details

Completed

The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis

NCT05770271

Conditions: Dermatitis, Eczema, Groin Infection, +10 more
Locations: Huinuode Biotechnology Co., Ltd. Qingdao, China

View Trial Details

Completed

GB-EZ-SIM03 Probiotics Study for Childhood Eczema

NCT05607511

Conditions: Dermatitis, Eczema, Skin Diseases, +2 more
Locations: Department of Paediatrics, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin Hong Kong

View Trial Details

Completed

Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use

NCT04404075

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: UCSF Psoriasis and Skin Treatment Center San Francisco, California, United States

View Trial Details

Completed

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

NCT04800315

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations: Clinical Research Center of Alabama Birmingham, Alabama, United States

Local Institution - 119 Birmingham, Alabama, United States

Cahaba Dermatology Birmingham, Alabama, United States

Local Institution - 114 Birmingham, Alabama, United States

View all 157 locations

View Trial Details

Completed

HPA Axis Study in Adults

NCT01408511

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: PAREXEL Bloemfontein Bloemfontein, South Africa

PAREXEL George George, South Africa

PAREXEL Port Elizabeth Port Elizabeth, South Africa

View Trial Details

Completed

HPA Axis Study in Japanese Adults

NCT01407510

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations: Kawaguchi Kogyo General Hospital Saitama, Japan

Clinical Research Hospital Tokyo Tokyo, Japan

Tokyo Women's Medical University Tokyo, Japan

View Trial Details

Completed

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

NCT04760314

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations: Yanagihara dermatology clinic Ainokawa, Ichikawa-shi, Chiba, Japan

Kawashima Dermatology Clinic Ichikawa-shi, Chiba, Japan

Charme Clinique Matsudo, Chiba, Japan

Yasumoto Dermatology Clinic Chikushino-shi, Fukuoka, Japan

View all 37 locations

View Trial Details